leisure time -WSS

leisure time

author：knowledge 2025-09-06 04:13:55 - browse：4645

Diversity in clinical trials concept — Adobe

The persistent lack of diversity among participants in clinical trials is a critical issue that is harming both populations that have long been left out of pivotal medical studies and the entire biomedical research enterprise, according to the authors of a report released Tuesday by the National Academies of Sciences, Engineering and Medicine.

Describing the need to move away from trials that focus largely on white men as “urgent,” the report’s authors called for a paradigm shift that gives less power to institutions that fund and conduct clinical research and more to communities under study. The sternly worded report said funding to include and recruit more diverse participants should be a priority that is enforced and said such investments could eventually lead to massive cost savings as the nation’s health disparities are reduced.

“An equitable clinical research enterprise would include trials and studies that match the demographics of the disease burden under study,” the report said. “However, we remain far from achieving this goal.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Cancer, immunology, HIV research ensnared in fetal tissue politics

WSS

Kim Kardashian sparks debate on benefits of full

Where are patients getting their prescriptions for GLP

Readout Newsletter: Illumina, CRISPR, Regeneron

Where are patients getting their prescriptions for GLP

The perfect storm of weather conditions that led to the devastating wildfires in Maui

What Kate Middleton's cancer revelation might teach the world

hotspot

leisure time

leisure time

Affirmative action in medical school literally saved lives

Iran moves toward freeing 5 American citizens who had been imprisoned, in rare deal

State Dept. review finds Biden bears some blame for Afghanistan failures

This gene therapy has record $4.25 million price. It's saved children.

Apple is now the first public company to be valued at $3 trillion

Some of the ways extreme heat will change life as we know it

In age of alternative facts, a scholarly course on calling out crap

Trump, Nauta plead not guilty to new classified docs charges but De Oliveira still not arraigned

Drug repurposing or repositioning? The language matters

With Wegovy coverage, Medicare patients may face high costs

focus

Feng Zhang suggests Editas didn’t move quickly enough to find product targets

Some of the ways extreme heat will change life as we know it

What Kate Middleton's cancer revelation might teach the world

Steward Health Care expansion into Malta flopped

'Disease catastrophe' looms in Sudan as health conditions deteriorate, medics warn

TB outbreak tied to bone grafts underscores testing shortcomings

focus

Wikipedia

focus

knowledge